A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer

ABSTRACT: To evaluate the efficacy and safety of pyrotinib combined with capecitabine in patients with metastatic her-2 positive colorectal cancer after standard treatment.

DISEASE(S): Her-2 Positive Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2326840 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR